Backed By Key Investors, Kala Pharmaceuticals Taps Its First CEO
This article was originally published in The Pink Sheet Daily
Executive Summary
As it develops therapies that target mucosal tissues, the seed-stage start-up hires Sanofi-Pasteur veteran Guillaume Pfefer in advance of a Series A round of funding.